Analysis of circRNA,mRNA and miRNA in depolarized neuroblastoma cells
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
应用场景：
创建时间：
2020-03-06
相关数据集
RNA expression profiling in cardiomyocytes. RNA expression profiling in cardiomyocytes
Using the highly sensitive RNA array, we assessed the effect of 11β-HSD1 and BVT.2733 on modulating RNAs expression in the neonatal rat ventricular cardiomyocytes. Overall design: In this study, sampl
NIAID Data Ecosystem50
Parameters defining the neuroblastoma cell agents.
MYCN’s expression levels without some or all of the listed mutations of MYCN and ALK were derived from an experimental study [90].vThe wild-type MAPK/RAS pathway’s signalling activity was derived from
Figshare2024-12-23 更新30
Differential RNA expression in human neck and squamous cell carcinoma cell lines (T-HEp3 and D-HEp3).. Differential RNA expression in human neck and squamous cell carcinoma cell lines (T-HEp3 and D-HEp3).
We report the RNA expression profile in the tumorigenic (T-HEp3) and dormant (D-HEp3) HNSCC cell lines. T-HEp3 is a human epidermoid carcinoma, which grows on chorioallantoic membreane and metastasize
NIAID Data Ecosystem20
Characterization of RNA context tumor associated macrophages and related extracellular vesicles. Characterization of RNA context tumor associated macrophages and related extracellular vesicles
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
NIAID Data Ecosystem40
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [microarray]
ALK mutations occur in 10% of primary neuroblastoma and represent a major target for precision treatment. In combination with MYCN amplification, ALK mutations infer an ultra-high-risk phenotype with
NIAID Data Ecosystem30
